PL1803447T3 - Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka - Google Patents

Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka

Info

Publication number
PL1803447T3
PL1803447T3 PL04774809T PL04774809T PL1803447T3 PL 1803447 T3 PL1803447 T3 PL 1803447T3 PL 04774809 T PL04774809 T PL 04774809T PL 04774809 T PL04774809 T PL 04774809T PL 1803447 T3 PL1803447 T3 PL 1803447T3
Authority
PL
Poland
Prior art keywords
hydralazine
support
pharmaceutical composition
sustained release
cancer treatment
Prior art date
Application number
PL04774809T
Other languages
English (en)
Inventor
Flores Luis Estrada
González Alfonso Dueñas
GARCÍA Arturo BORBOLLA
Martínez Raúl Serna
HERNÁNDEZ Alfredo RIVERA
Betancourt Alejandro Mohar
Original Assignee
Psicofarma S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psicofarma S A De C V filed Critical Psicofarma S A De C V
Publication of PL1803447T3 publication Critical patent/PL1803447T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL04774809T 2004-09-09 2004-09-09 Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka PL1803447T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/MX2004/000064 WO2006028362A1 (es) 2004-09-09 2004-09-09 Composición farmacéutica de liberación prolongada de hidralazina y su uso como apoyo para el tratamiento del cáncer
EP04774809A EP1803447B1 (en) 2004-09-09 2004-09-09 Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Publications (1)

Publication Number Publication Date
PL1803447T3 true PL1803447T3 (pl) 2010-05-31

Family

ID=36036613

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04774809T PL1803447T3 (pl) 2004-09-09 2004-09-09 Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka

Country Status (17)

Country Link
US (1) US7820200B2 (pl)
EP (1) EP1803447B1 (pl)
JP (1) JP4814885B2 (pl)
CN (1) CN101039661A (pl)
BR (1) BRPI0419032B8 (pl)
CA (1) CA2579220C (pl)
CR (1) CR9035A (pl)
CY (1) CY1110508T1 (pl)
DE (1) DE602004022205D1 (pl)
DK (1) DK1803447T3 (pl)
ES (1) ES2330227T3 (pl)
MX (1) MX2007002871A (pl)
NZ (1) NZ554360A (pl)
PL (1) PL1803447T3 (pl)
PT (1) PT1803447E (pl)
SI (1) SI1803447T1 (pl)
WO (1) WO2006028362A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4521402A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of hydrazine
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
CA2371940C (en) * 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20050226926A1 (en) * 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
EP1559433A4 (en) * 2002-10-22 2009-11-04 Dainippon Sumitomo Pharma Co STABILIZED COMPOSITION

Also Published As

Publication number Publication date
CA2579220C (en) 2013-01-08
BRPI0419032B8 (pt) 2021-05-25
DE602004022205D1 (de) 2009-09-03
ES2330227T3 (es) 2009-12-07
WO2006028362A1 (es) 2006-03-16
EP1803447A1 (en) 2007-07-04
PT1803447E (pt) 2009-08-14
US20090042889A1 (en) 2009-02-12
EP1803447B1 (en) 2009-07-22
CA2579220A1 (en) 2006-03-16
CR9035A (es) 2009-03-27
JP2008512450A (ja) 2008-04-24
MX2007002871A (es) 2007-04-23
CN101039661A (zh) 2007-09-19
BRPI0419032B1 (pt) 2019-02-05
NZ554360A (en) 2009-11-27
BRPI0419032A (pt) 2007-12-11
US7820200B2 (en) 2010-10-26
CY1110508T1 (el) 2015-04-29
SI1803447T1 (sl) 2010-01-29
DK1803447T3 (da) 2009-10-12
JP4814885B2 (ja) 2011-11-16

Similar Documents

Publication Publication Date Title
HK1107672A1 (en) Conveniently implantable sustained release drug compositions
EP1940361A4 (en) PHARMACEUTICAL DOSAGE FORMS HAVING CONTROLLED AND / OR IMMEDIATE RELEASE PROPERTIES
ZA200801158B (en) Sustained drug release composition
HK1124241A1 (en) Azaindazole compounds and therapeutic uses thereof
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
EP1838291A4 (en) PHARMACEUTICAL FORMULATIONS AND METHOD OF USE THEREOF
IL177047A0 (en) Oxazole derivatives, preparation and therapeutic use thereof
EP1802346A4 (en) PHARMACEUTICAL COMPOSITION WITH EXTENDED RELEASE
EP1895991A4 (en) MODIFIED RELEASE FORMULATIONS OF ANTI-IRRITABLE DRUGS
HK1080397A1 (en) An acrylic acid-based binder composition and the pharmaceutical composition and transdermal therapeutic system thereof
HK1105886A1 (en) Pharmaceutical compositions comprising l-733060 for use in the treatment of cancer tumours l-733060
EP1753405A4 (en) SLOW RELEASE PHARMACEUTICAL PREPARATION
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
PL1828137T3 (pl) 4-cykloalkilo-podstawione pochodne tetrahydrochinoliny i ich zastosowanie jako leki
EP1928247A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
ZA200701578B (en) Combination anticancer therapy and pharmaceutical compositions therefore
IL180316A0 (en) Quinolone-containing medicinal composition
EP1803452A4 (en) ESTER DERIVATIVE AND ITS PHARMACEUTICAL USE THEREOF
EP1809298A4 (en) NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS CONTAINING SPIROSTENOL
SI1803447T1 (sl) Farmacevtski sestavek za zadrĺ˝evano sproĺ äśanje hidralazina in njegova uporaba kot podrpora zdravljenju raka
IL185691A0 (en) Novel compounds derived from 5-thioxylose and therapeutic use thereof
ZA200704650B (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
GB0409356D0 (en) Patient support structures
ZA200606408B (en) Controlled release pharmaceutical compositions